Management of Pruritus in Elderly Patients

Initial Assessment and First-Line Treatments

For a 93-year-old female on prednisone with pruritus, the British Journal of Dermatology recommends topical emollients and moderate-potency topical corticosteroids as first-line treatment, with oral non-sedating antihistamines as adjunctive therapy if needed 1, 2
Rule out other causes of pruritus, including drug effects, infections, or underlying systemic conditions, as suggested by the Journal of Clinical Oncology 3, 4
Begin with topical treatments, including emollients with high lipid content, which are preferred in elderly skin, according to the British Journal of Dermatology 2
Moderate-potency topical corticosteroids, such as clobetasone butyrate, should be used for at least 2 weeks to exclude asteatotic eczema, as recommended by the British Journal of Dermatology 2
Topical menthol 0.5% can provide symptomatic relief, as suggested by the British Journal of Dermatology and Annals of Oncology 1, 5

If pruritus persists after initial topical treatments, consider non-sedating antihistamines, such as fexofenadine 180 mg or loratadine 10 mg, as recommended by the British Journal of Dermatology 1, 2
Combination of H1 and H2 antagonists, such as fexofenadine and cimetidine, may also be considered, according to the British Journal of Dermatology 2
Topical anti-itch remedies, such as refrigerated menthol and pramoxine, can be used, as suggested by the Journal of Clinical Oncology 6, 7

Avoid sedative antihistamines in elderly patients, as they may increase the risk of falls and cognitive impairment, according to the British Journal of Dermatology 2
Gabapentin may be beneficial for elderly patients with persistent pruritus, but should be started at lower doses and titrated slowly, as recommended by the British Journal of Dermatology 2

Consider gabapentin or pregabalin if pruritus remains uncontrolled, as suggested by the British Journal of Dermatology and Annals of Oncology 2, 5
For pruritus without rash that is severe or limiting self-care activities, gabapentin or pregabalin may be considered, according to the British Journal of Dermatology and Annals of Oncology 2, 5
Consider referral to dermatology, as recommended by the Journal for ImmunoTherapy of Cancer and Annals of Oncology 5, 8

Reassess after 2 weeks of treatment to evaluate response, as suggested by Annals of Oncology 5
If symptoms worsen or don't improve, consider advancing to the next treatment option, according to Annals of Oncology 5
Refer to secondary care if there is diagnostic doubt or if primary care management does not relieve symptoms, as recommended by the British Journal of Dermatology 1, 2

Limit topical steroid use to avoid skin atrophy, especially in elderly skin, as suggested by Annals of Oncology 5
Avoid long-term use of sedative antihistamines in the elderly, except in palliative care settings, according to the British Journal of Dermatology 2